Select Location
What is your delivery location?
We need your delivery location to continue browsing
Select Location
We need your delivery location to continue browsing
Prescription Required
cipla
120 tablets in Bottle
Sorafenib
Keep in cold place
Delivering To:
Overview
Soranib 200mg tablet is a prescription based anticancer medicine. It is used to treat certain types of cancer such as liver, kidney, and thyroid cancer. This medicine helps to prevent the multiplication of cancer cells. This tablet belongs to a class of medication known as a tyrosine kinase inhibitor. This is an anti-cancer medication that interferes with the growth and spread of cancerous cells.
Kidney Cancer
The human body shows undesired symptoms after taking the Soranib 200mg Tablet. Usually, they disappear with time as the body adjusts to the medicine. These side effects don't need special medical attention. It is advised to consult your doctor if these symptoms become unmanageable.
Common side effects include:
Fatigue
Weight loss
Abdominal pain
Vomiting
Fever
Bloating
Blurred vision
Nausea
Bleeding gums
Headache
Difficulty in breathing
Diarrhea
Hand-foot skin reaction
Rash
Pounding in the ears
Inform your doctor immediately if you experience any persistent or unusual side effects.
Take Soranib 200mg Tablet as prescribed by your doctor. Swallow the tablet as whole with a glass of water and do not crush or break the tablet. Take this medicine on an empty stomach one hour before or two hours after the meals. In case of an overdose, the doctor will provide emergency medical treatment. It is advisable not to change your regular dosing schedule without taking suggestions from your doctor.
Alcohol
unsafe
Avoid the consumption of alcohol while taking Soranib 200mg Tablet, as alcohol can reduce the effectiveness of the medicine and worsen the symptoms
Pregnancy
consult your doctor
Do not take Soranib 200mg Tablet without consulting the doctor in case of pregnancy, as it is an unsafe medicine during this period.
Breast Feeding
consult your doctor
Soranib 200mg Tablet is unsafe to use during breastfeeding as it may cause toxicity to the baby.
Driving
danger
Soranib 200mg Tablet may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving or operating heavy machinery.
Kidney
caution
Soranib 200mg Tablet is safe for use in kidney disease if prescribed by the doctor. No dosage adjustment is necessary for this Tablet.
Liver
caution
Consumption of Soranib 200mg Tablet should be avoided without informing the doctor if you have any liver-related issues.
It is advisable not to miss a dose. If you miss a scheduled dose of this medicine, contact your doctor immediately.
Soranib tablets are used to treat certain types of cancer including liver, kidney, and thyroid cancer. This medicine helps to prevent the multiplication of cancer cells.
Soranib tablets are anti-cancer medications. It works by blocking the action of a protein that signals the cancer cells to multiply. This helps in slowing down the growth of cancer cells.
Some common side effects are nausea, fever, abdominal pain, irregular heartbeat, seizures, diarrhea, bleeding, fatigue, indigestion, etc.
This medicine may affect your vision. Do not drive if any symptoms occur.
This medicine is not recommended for breastfeeding unless it is necessary.
At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.
Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.
Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.
We currently ship to:
Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!
1. Abdelgalil, A. A., Alkahtani, H. M., & Al-Jenoobi, F. I. (2019). Sorafenib. Profiles of drug substances, excipients, and related methodology, 44, 239-266.
2. Rini, B. I. (2006). Sorafenib. Expert opinion on pharmacotherapy, 7(4), 453-461.
3. Hassan, M. H., Abou-Elkhair, R. A., Hassan, A. E., & Mousa, H. S. (2025). Analytical quality by design-compliant development of quantitative 1H-and 19F-nuclear magnetic resonance methods for the analytical evaluation of the anti-cancer drug, sorafenib. Microchemical Journal, 208, 112544.
4. SANKAR, P. R., Gunturu, G. S. K., & Ramya, V. Development and validation of RP-HPLC method for the determination of Sorafenib (A novel kinase inhibitor drug) In Pharmaceutical dosage form.
5. Sankar, P. R., Viswanath, A., Eswarudu, M. M., Babu, P. S., Divya, B., Neelima, K., & Devi, K. R. (2021). Development and validation of RP-HPLC method for the determination of sorafenib in pharmaceutical dosage form. Int. J. Pharm. Sci. Rev. Res, 69(1), 15-23.
cipla
Written By
Venika Choudhary
Medical Content Writer @ Magicine Pharma
I hold an M.Sc. in Microbiology and have a strong academic foundation in microbial sciences and applied biotechnology. I began my career with extensive hands-on research at CSIR laboratories, focusing on fungal enzyme production, studying fungal diversity in various ecosystems, and developing bio-pesticides as sustainable alternatives to chemical pesticides. This work deepened my understanding of fungal biology, bioactive compounds, and their pharmaceutical and agricultural applications. Transitioning from research, I now work as a medical content writer, where I combine my scientific expertise with a passion for clear and reliable healthcare communication. I apply my research background to create patient-friendly, compliant content for pharmaceutical companies and healthcare platforms, ensuring science is both trustworthy and accessible. Specializing in clear, accurate, and engaging content, I help patients make informed decisions and support pharmaceutical companies in delivering trusted information. Whether writing product descriptions, crafting disease awareness articles, or composing drug information leaflets, I consistently meet regulatory standards and address audience needs, making my content an asset for healthcare brands.
Reviewed By
Dr. Aditya Sarin - MBBS, MD, DrNB - Consultant Medical Oncology
Dr. Aditya Sarin, MBBS, MD, DrNB, is a highly qualified medical oncologist with profound research and clinical expertise, currently working at Sir Ganga Ram Hospital, New Delhi. He is also a member of the European Society of Medical Oncology (ESMO), a non-profit European organization dedicated to eradicating cancer by promoting comprehensive cancer care and advancing medical oncology. He has been honored with several awards, including the International Cancer Foundation scholarship (ESMO congress, 2022) and Young Medical Oncologist of the Year (Times of India, 2024). He is well-known for his breakthrough in oncology. Dr. Sarin is passionate about converting complex health information into a concise and clear form that is understandable to everyone, aiming to create awareness and cancer care among people.